Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism
Multi-Modal fMRI/NIRS for Estimation of CMRO2 for Neuroimaging Studies of Drug Abuse and Psychiatric Illness Problems
Status: Enrolling
Updated:  4/4/2013
McLean Imaging Center
mi
from
Belmont, MA
Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism
Multi-Modal fMRI/NIRS for Estimation of CMRO2 for Neuroimaging Studies of Drug Abuse and Psychiatric Illness Problems
Status: Enrolling
Updated: 4/4/2013
McLean Imaging Center
mi
from
Belmont, MA
Click here to add this to my saved trials
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments.
Status: Enrolling
Updated:  4/9/2013
Duke Univ Med Ctr
mi
from
Durham, NC
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments.
Status: Enrolling
Updated: 4/9/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Assess the Cardiac Safety of Oritavancin in Healthy Volunteers
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Design, Study With an Open-Label Positive-Control, to Assess the Cardiac Safety of Oritavancin in Healthy Volunteers
Status: Enrolling
Updated:  4/16/2013
Spaulding Clinical
mi
from
West Bend, WI
A Study to Assess the Cardiac Safety of Oritavancin in Healthy Volunteers
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Design, Study With an Open-Label Positive-Control, to Assess the Cardiac Safety of Oritavancin in Healthy Volunteers
Status: Enrolling
Updated: 4/16/2013
Spaulding Clinical
mi
from
West Bend, WI
Click here to add this to my saved trials
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Status: Enrolling
Updated:  4/20/2013
Delmont Surgery Center
mi
from
Greensburg, PA
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Status: Enrolling
Updated: 4/20/2013
Delmont Surgery Center
mi
from
Greensburg, PA
Click here to add this to my saved trials
A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents
A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents for Refining Immunologic Assays Supporting the Development of the Protective Malaria Vaccine NMRC-M3V-D/Ad-PfCA (AdBa)
Status: Enrolling
Updated:  4/25/2013
Naval Medical Research Center Clinical Trials Center
mi
from
Bethesda, MD
A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents
A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents for Refining Immunologic Assays Supporting the Development of the Protective Malaria Vaccine NMRC-M3V-D/Ad-PfCA (AdBa)
Status: Enrolling
Updated: 4/25/2013
Naval Medical Research Center Clinical Trials Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765
Open-Label, Randomized, 4-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765
Status: Enrolling
Updated:  5/9/2013
Clinical Research Facility
mi
from
Newark, NJ
A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765
Open-Label, Randomized, 4-Way Crossover Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765
Status: Enrolling
Updated: 5/9/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Biosynthesis of PGD2 in Vivo
A Pilot Study to Measure Plasma and Urinary Prostaglandin D2 Metabolites Evoked by Niacin
Status: Enrolling
Updated:  5/14/2013
University of Pennsylvania Hospital
mi
from
Phila., PA
Biosynthesis of PGD2 in Vivo
A Pilot Study to Measure Plasma and Urinary Prostaglandin D2 Metabolites Evoked by Niacin
Status: Enrolling
Updated: 5/14/2013
University of Pennsylvania Hospital
mi
from
Phila., PA
Click here to add this to my saved trials
Simons Variation in Individuals Project, Functional Common Acquisition Protocol
Functional Common Acquisition Protocol Phase of the Simons VIP
Status: Enrolling
Updated:  5/16/2013
University of California - San Francisco
mi
from
San Francisco, CA
Simons Variation in Individuals Project, Functional Common Acquisition Protocol
Functional Common Acquisition Protocol Phase of the Simons VIP
Status: Enrolling
Updated: 5/16/2013
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects
A Phase 1, Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of CC-220 and to Explore the Effect of Food on the Bioavailability of CC-220 in Healthy Subjects
Status: Enrolling
Updated:  6/5/2013
Covance Clinical Research Unit
mi
from
Madison, WI
2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects
A Phase 1, Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of CC-220 and to Explore the Effect of Food on the Bioavailability of CC-220 in Healthy Subjects
Status: Enrolling
Updated: 6/5/2013
Covance Clinical Research Unit
mi
from
Madison, WI
Click here to add this to my saved trials
A Safety Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in HCV Genotype 1 Infected Patients
A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of Single and Multiple Ascending Oral Doses of TG-2349, and Followed by a Dose-Ranging Study in Hepatitis C Genotype 1 Infected Patients
Status: Enrolling
Updated:  6/17/2013
WCCT
mi
from
Cypress, CA
A Safety Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in HCV Genotype 1 Infected Patients
A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of Single and Multiple Ascending Oral Doses of TG-2349, and Followed by a Dose-Ranging Study in Hepatitis C Genotype 1 Infected Patients
Status: Enrolling
Updated: 6/17/2013
WCCT
mi
from
Cypress, CA
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects
A Phase 1, Randomized, Blinded, Placebo-Controlled, Multiple IV Administration, Sequential-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects
Status: Enrolling
Updated:  6/20/2013
PAREXEL Baltimore EPCU
mi
from
Baltimore, MD
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects
A Phase 1, Randomized, Blinded, Placebo-Controlled, Multiple IV Administration, Sequential-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects
Status: Enrolling
Updated: 6/20/2013
PAREXEL Baltimore EPCU
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effects of Blueberry on Cognition and Mobility in Older Adults
Effects of Dietary Blueberry Supplementation on Cognition and Mobility in Healthy Older Adults
Status: Enrolling
Updated:  6/25/2013
Jean Meyer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Effects of Blueberry on Cognition and Mobility in Older Adults
Effects of Dietary Blueberry Supplementation on Cognition and Mobility in Healthy Older Adults
Status: Enrolling
Updated: 6/25/2013
Jean Meyer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Atlanta, GA
Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Overland Park, KA
Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
A Multicenter, Randomized, Double-blind, Double-dummy, 2-period Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Pharmacokinetics and Safety of JNJ-54452840 Following Single Intravenous Doses to Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated:  7/4/2013
Clinical Research Facility
mi
from
Santa Clara, CA
To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Pharmacokinetics and Safety of JNJ-54452840 Following Single Intravenous Doses to Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated: 7/4/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Role of Flavanols in Exercise and Aging
Acute and Long-term Effects of Dietary Flavanols on Local Control of Skeletal Muscle Blood Flow During Exercise in Young and Old Humans
Status: Enrolling
Updated:  7/8/2013
University of Texas at Austin: Environmental and Autonomic Physiology Laboratory
mi
from
Austin, TX
Role of Flavanols in Exercise and Aging
Acute and Long-term Effects of Dietary Flavanols on Local Control of Skeletal Muscle Blood Flow During Exercise in Young and Old Humans
Status: Enrolling
Updated: 7/8/2013
University of Texas at Austin: Environmental and Autonomic Physiology Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets
Relative Bioavailability of Two Newly Developed Extended Release FDC Tablet Strengths (5mg/1000mg and 2.5 mg/750 mg) of Linagliptin/Metformin Extended Release Compared With the Free Combination of Linagliptin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)
Status: Enrolling
Updated:  7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets
Relative Bioavailability of Two Newly Developed Extended Release FDC Tablet Strengths (5mg/1000mg and 2.5 mg/750 mg) of Linagliptin/Metformin Extended Release Compared With the Free Combination of Linagliptin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)
Status: Enrolling
Updated: 7/10/2013
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Status: Enrolling
Updated:  7/12/2013
Rothman Center for Neuropsychiatry
mi
from
St. Petersburg, FL
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Status: Enrolling
Updated: 7/12/2013
Rothman Center for Neuropsychiatry
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing
A Double-Blind, Randomized, Placebo-Controlled, Sequential, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-036 in Healthy Subjects
Status: Enrolling
Updated:  7/12/2013
Covance-Evansville
mi
from
Evansville, IN
Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing
A Double-Blind, Randomized, Placebo-Controlled, Sequential, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-036 in Healthy Subjects
Status: Enrolling
Updated: 7/12/2013
Covance-Evansville
mi
from
Evansville, IN
Click here to add this to my saved trials
Novel Methodology to Measure Protein Accumulation
Novel Methodology to Measure Protein Accumulation
Status: Enrolling
Updated:  7/15/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Novel Methodology to Measure Protein Accumulation
Novel Methodology to Measure Protein Accumulation
Status: Enrolling
Updated: 7/15/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
RDEA3170 and Febuxostat Drug Interaction Study
A Phase 1 Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between RDEA3170 and Febuxostat in Healthy Adult Male Subjects
Status: Enrolling
Updated:  7/16/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
RDEA3170 and Febuxostat Drug Interaction Study
A Phase 1 Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between RDEA3170 and Febuxostat in Healthy Adult Male Subjects
Status: Enrolling
Updated: 7/16/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract
A Phase 1, Open-Label 4 Sequence 4 Period Crossover Study In Healthy Volunteers To Estimate The Effect Of Active Pharmaceutical Ingredient Particle Size And Lubrication On The Bioavailability Of A Single 125 Mg Dose Of Palbociclib (PD-0332991) Administered Under Fasted Conditions
Status: Enrolling
Updated:  7/18/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal Tract
A Phase 1, Open-Label 4 Sequence 4 Period Crossover Study In Healthy Volunteers To Estimate The Effect Of Active Pharmaceutical Ingredient Particle Size And Lubrication On The Bioavailability Of A Single 125 Mg Dose Of Palbociclib (PD-0332991) Administered Under Fasted Conditions
Status: Enrolling
Updated: 7/18/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects
A Phase 1, Open-label, Randomized, 2-period, Crossover, Exploratory Study to Investigate the Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects
Status: Enrolling
Updated:  7/18/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects
A Phase 1, Open-label, Randomized, 2-period, Crossover, Exploratory Study to Investigate the Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects
Status: Enrolling
Updated: 7/18/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)
A Double-Blind, Randomized, Placebo-Controlled, Sequential, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-036 in Healthy Subjects
Status: Enrolling
Updated:  7/25/2013
Covance-Evansville
mi
from
Evansville, IN
Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)
A Double-Blind, Randomized, Placebo-Controlled, Sequential, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of VBY-036 in Healthy Subjects
Status: Enrolling
Updated: 7/25/2013
Covance-Evansville
mi
from
Evansville, IN
Click here to add this to my saved trials
RDEA3170 AME Study
A Phase 1 Absorption, Metabolism and Excretion Study of [14C]RDEA3170 Orally Administered to Healthy Adult Male Subjects
Status: Enrolling
Updated:  7/26/2013
Clinical Research Facility
mi
from
Milwaukee, WI
RDEA3170 AME Study
A Phase 1 Absorption, Metabolism and Excretion Study of [14C]RDEA3170 Orally Administered to Healthy Adult Male Subjects
Status: Enrolling
Updated: 7/26/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)
An Open Label Trial to Assess the Effects of Food on the Pharmacokinetic Parameters of Obeticholic Acid (OCA)
Status: Enrolling
Updated:  7/31/2013
Celerion
mi
from
Tempe, AZ
Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA)
An Open Label Trial to Assess the Effects of Food on the Pharmacokinetic Parameters of Obeticholic Acid (OCA)
Status: Enrolling
Updated: 7/31/2013
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated:  8/8/2013
Axis Clinical Trials
mi
from
Los Angeles, CA
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated: 8/8/2013
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated:  8/8/2013
Prism Research
mi
from
St. Paul, MN
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated: 8/8/2013
Prism Research
mi
from
St. Paul, MN
Click here to add this to my saved trials
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated:  8/8/2013
New Orleans Center for Clinical Research - Knoxville
mi
from
Knoxville, TN
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated: 8/8/2013
New Orleans Center for Clinical Research - Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated:  8/8/2013
Alamo Medical Research
mi
from
San Antonio, TX
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)
Status: Enrolling
Updated: 8/8/2013
Alamo Medical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users
A Randomized, Single-Dose, Placebo-Controlled, Double-Blind, 3-Way Crossover Study to Determine the Relative Abuse Potential of Intravenous Oxycodone Hydrochloride Alone or in Combination With Intravenous Naltrexone Hydrochloride in Opioid Experienced Non-Dependent Subjects
Status: Enrolling
Updated:  8/16/2013
Pfizer Investigational Site
mi
from
West Jordan, UT
A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users
A Randomized, Single-Dose, Placebo-Controlled, Double-Blind, 3-Way Crossover Study to Determine the Relative Abuse Potential of Intravenous Oxycodone Hydrochloride Alone or in Combination With Intravenous Naltrexone Hydrochloride in Opioid Experienced Non-Dependent Subjects
Status: Enrolling
Updated: 8/16/2013
Pfizer Investigational Site
mi
from
West Jordan, UT
Click here to add this to my saved trials
Lesinurad Interaction Study With Ranitidine
A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Effects of Ranitidine on the Pharmacokinetics of Lesinurad in Healthy Adult Male Subjects
Status: Enrolling
Updated:  8/23/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Lesinurad Interaction Study With Ranitidine
A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Potential Effects of Ranitidine on the Pharmacokinetics of Lesinurad in Healthy Adult Male Subjects
Status: Enrolling
Updated: 8/23/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects
A Phase 1, Single-Dose, Open-Label, 3-Period, Randomized Crossover Study to Assess the Relative Bioavailability Between Two ASP015K Tablet Formulations and the Food Effect on a New Tablet Formulation in Healthy Adult Subjects
Status: Enrolling
Updated:  8/23/2013
Parexel - Early Phase Clinical Unit
mi
from
Baltimore, MD
A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects
A Phase 1, Single-Dose, Open-Label, 3-Period, Randomized Crossover Study to Assess the Relative Bioavailability Between Two ASP015K Tablet Formulations and the Food Effect on a New Tablet Formulation in Healthy Adult Subjects
Status: Enrolling
Updated: 8/23/2013
Parexel - Early Phase Clinical Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of General Anesthetics on Upper Airway Collapsibility in Healthy Subjects
The Effects of Sevoflurane, Propofol, and Carbon Dioxide 'Reversal' on Upper Airway Collapsibility in Healthy, Adult Subjects
Status: Enrolling
Updated:  8/27/2013
Massachusetts General Hospital
mi
from
Boston, MA
The Effects of General Anesthetics on Upper Airway Collapsibility in Healthy Subjects
The Effects of Sevoflurane, Propofol, and Carbon Dioxide 'Reversal' on Upper Airway Collapsibility in Healthy, Adult Subjects
Status: Enrolling
Updated: 8/27/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Status: Enrolling
Updated:  8/28/2013
Brigham and Women's Hospital, Massachusetts General Hospital
mi
from
Boston, MA
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Status: Enrolling
Updated: 8/28/2013
Brigham and Women's Hospital, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Status: Enrolling
Updated:  8/28/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
Status: Enrolling
Updated: 8/28/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Characterization Of The Effect Of Food On Palbociclib Absorption
A Phase 1, Open-Label 4 Sequence 4 Period Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Estimate The Effect Of Food On The Bioavailability Of Palbociclib
Status: Enrolling
Updated:  9/9/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Characterization Of The Effect Of Food On Palbociclib Absorption
A Phase 1, Open-Label 4 Sequence 4 Period Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Estimate The Effect Of Food On The Bioavailability Of Palbociclib
Status: Enrolling
Updated: 9/9/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Caregiver Stress: Interventions to Promote Health and Wellbeing
Caregiver Stress: Interventions to Promote Health and Wellbeing
Status: Enrolling
Updated:  9/11/2013
Emory Universtiy
mi
from
Atlanta, GA
Caregiver Stress: Interventions to Promote Health and Wellbeing
Caregiver Stress: Interventions to Promote Health and Wellbeing
Status: Enrolling
Updated: 9/11/2013
Emory Universtiy
mi
from
Atlanta, GA
Click here to add this to my saved trials
Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study
Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study
Status: Enrolling
Updated:  9/12/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study
Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study
Status: Enrolling
Updated: 9/12/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Status: Enrolling
Updated:  9/17/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Topeka, KA
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Status: Enrolling
Updated: 9/17/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Topeka, KA
Click here to add this to my saved trials
The Effect of Eggs on Postprandial Metabolism
The Effect of Eggs on Postprandial Metabolism: A Randomized, Controlled Crossover Pilot Study in Older, Overweight Adults
Status: Enrolling
Updated:  9/23/2013
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
The Effect of Eggs on Postprandial Metabolism
The Effect of Eggs on Postprandial Metabolism: A Randomized, Controlled Crossover Pilot Study in Older, Overweight Adults
Status: Enrolling
Updated: 9/23/2013
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily
Status: Enrolling
Updated:  9/23/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily
Status: Enrolling
Updated: 9/23/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily
Status: Enrolling
Updated:  9/23/2013
Clinical Research Facility
mi
from
Houston, TX
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily
Status: Enrolling
Updated: 9/23/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily
Status: Enrolling
Updated:  9/23/2013
Clinical Research Facility
mi
from
Beloit, WI
PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily
A Multicenter, Double Blind, Placebo-Controlled Study of Pepto-Bismol® (Bismuth Subsalicylate) on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral TECFIDERA™ (Dimethyl Fumarate) Delayed-Release Capsules Twice Daily
Status: Enrolling
Updated: 9/23/2013
Clinical Research Facility
mi
from
Beloit, WI
Click here to add this to my saved trials
A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Participants
A Single-Dose, Open-Label, Randomized, 4-Period, 5-Treatment Crossover Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Subjects
Status: Enrolling
Updated:  9/25/2013
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Participants
A Single-Dose, Open-Label, Randomized, 4-Period, 5-Treatment Crossover Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Subjects
Status: Enrolling
Updated: 9/25/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects
Status: Enrolling
Updated:  9/26/2013
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects
Status: Enrolling
Updated: 9/26/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects
Status: Enrolling
Updated:  9/26/2013
Clinical Research Facility
mi
from
Omaha, NE
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects
Status: Enrolling
Updated: 9/26/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects
Status: Enrolling
Updated:  9/26/2013
Clinical Research Facility
mi
from
Newark, NJ
A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants
Phase 1, Open-label, Randomized, Parallel Study to Assess the Pharmacokinetic Comparability of 2 Formulations and to Evaluate Pharmacokinetic Comparability of Guselkumab (CNTO1959) Delivered by 2 Different Devices in Healthy Subjects
Status: Enrolling
Updated: 9/26/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145
A Phase 1, Open-Label, Single-Sequence, 2-Period Study to Evaluate the Effect of Rifampin (a CYP3A Inducer) on the Pharmacokinetics of IPI-145 in Healthy Subjects
Status: Enrolling
Updated:  10/11/2013
Pra International
mi
from
Lenexa, KA
Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145
A Phase 1, Open-Label, Single-Sequence, 2-Period Study to Evaluate the Effect of Rifampin (a CYP3A Inducer) on the Pharmacokinetics of IPI-145 in Healthy Subjects
Status: Enrolling
Updated: 10/11/2013
Pra International
mi
from
Lenexa, KA
Click here to add this to my saved trials
An Investigator Initiated Study to Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth Athletes
Status: Enrolling
Updated:  10/13/2013
Noran Neurological Clinic
mi
from
Minneapolis, MN
An Investigator Initiated Study to Evaluate the Effectiveness of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth Athletes
Status: Enrolling
Updated: 10/13/2013
Noran Neurological Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials